Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantD
Dimension
Activity from announced rounds
All recorded activity
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $795.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in all activityChai Discovery
Building AI models to accelerate pre-clinical drug discovery
$400MSeries C
Role not disclosedCongruence Therapeutics
Develops small molecule correctors for diseases of protein misfolding
$39.5MSeries B
Role not disclosedAutomata
Builds AI-ready lab automation platforms for life sciences
$45MSeries C
Role not disclosed